Cavin-4 peptide immunization induces autoimmunity with features of immune-mediated rippling muscle disease
Cavin-4 has recently been identified as a target autoantigen in immune-mediated rippling muscle disease (iRMD); however, direct in vivo evidence linking cavin-4 directed immunity to muscle dysfunction is lacking. We therefore evaluated whether cavin-4 peptide immunization could induce cavin-4-directed autoimmunity and generate immunologic and muscle-related features associated with iRMD in mice. Wild-type C57BL/6 mice were immunized with mouse or human cavin-4 peptides (n=10/group); age-matched, unimmunized mice served as controls (n=5). Cavin-4 autoantibodies developed in both immunized groups, with stronger humoral responses in human peptide-immunized mice by ELISA and broader cavin-4 peptide enrichment by PhIP-Seq. Sera from human peptide-immunized mice recognized native cavin-4 on live C2C12 myotubes and were associated with impaired hanging-wire performance, elevated CK levels, mosaic reduction of cavin-4 immunoreactivity in skeletal muscle, and enhanced antigen-specific T-cell responses. These findings demonstrate that cavin-4 peptide immunization can induce biologically active, cavin-4-directed autoimmunity associated with functional, biochemical, and tissue-level abnormalities, although overt muscle rippling was not observed.
Authors
- Benjamin D. S. Clarkson (ORCID: https://orcid.org/0000-0003-2054-3486)
- Naveen Kumar Paramasivan (ORCID: https://orcid.org/0000-0002-2185-4385)
- Divyanshu Dubey (ORCID: https://orcid.org/0000-0001-6865-9045)
- Silvana B. De Lorenzo
- Reghann G. LaFrance‐Corey (ORCID: https://orcid.org/0009-0001-8292-683X)
- Haidara Kherbek (ORCID: https://orcid.org/0000-0002-0263-0378)
- Margherita Milone (ORCID: https://orcid.org/0000-0002-4338-9007)
- Carley Karsten (ORCID: https://orcid.org/0000-0002-4835-1999)
- Andrew M. Knight
- Yun Tang
Institutions
- Mayo Clinic (US)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2026-11-13
- DOI
- https://doi.org/10.3389/fimmu.2026.1955042
- Primary Topic
- Inflammatory Myopathies and Dermatomyositis
- Type
- article
- Field-Weighted Citation Impact
- 0.00